Despite common research initiatives in the study of Chinese herbal medicine for use in modern medication, Taiwanese firms are not looking to China for research partnerships, officials in Taiwan said.
"We don't see any close relationships between Taiwan and China right now," said Wu Maw-kuen (
Wu said Taiwanese biotechnology and pharmaceutical firms are limiting their contact with China to manufacturing projects.
Biotech industry pundits say Taiwan's proximity to China, the common language and culture shared between the two and strong use and belief in Chinese herbal medicine could be a source of strength for Taiwan's biotech industry.
Low-end center
Instead, firms here are doing research on their own and look at China as a location for low-end manufacturing, not for R&D.
Taiwan's own biotech industry is young. The big push into biotechnology did not begin until the middle of last year, when President Chen Shui-bian (
As is typical in Taiwan, local companies immediately followed the government's lead and piled into the sector.
Some companies, such as Uni-President Enterprises Corp (統一企業), had already launched their own biotech investment funds. But with the government putting its NT$52 billion stamp on the industry, a number of traditional firms, venture capitalists and banks jumped on the bandwagon.
By the end of last year, analysts estimate that nearly US$4 billion was available for investment in biotechnology -- mostly heading out of Taiwan, rather than being put into companies here.
It is hoped this money comes back in the form of technology transfer opportunities and possible joint development projects.
A history of high-tech and biotech investment shows the technology and partnership return-on-investment does come back around to Taiwan.
Money invested by Taiwanese venture capitalists in Canada brought it to the attention of some potential biotechnology partners.
"The strong will on the part of Taiwan to seek biotech partners and investment" is what attracted Normand Balthazard, president of BioCapital, a Montreal, Canada-based firm, to seek an Asia Pacific biotech partner in Taiwan last year.
He said investment throughout the "Quebec Corridor" of biotech companies by Taiwanese showed them to be both savvy and well informed about the industry.
Attracting foreign projects has also been a top priority for the government. US-based Tanox Inc recently signed a high-profile pharmaceutical deal worth NT$14 billion in Taiwan. The government helped Tanox find NT$12 billion in funding through the Industrial Bank of Taiwan (
Now, many in government are pushing for more international collaboration and conferences appear to be the primary tool.
Taiwan intends to use a coming APEC Biotechnology Conference on Wednesday and another conference, dubbed BioBusiness Asia 2002, on Thursday and Friday, to boost its international standing in the biotech industry.
"We would like to invite investors to come to Taiwan and see Asia," said Johnsee Lee (李鍾熙), director of the Biomedical Engineering Center (生醫工程中心) at the Industrial Technology Research Institute (工研院), a leading public funded research group in Taiwan.
Chinese contingent
The APEC conference will include officials from China, a rarity in Taiwan due to the political situation.
So far about 23 biotech companies from around Asia -- including four from Israel and five Taiwanese companies -- have signed up with BioBusiness Asia 2002 and will offer presentations on current research projects and company products during the event.
Lee expects as many as 30 firms will present at the conference.
Ruth Ann Minner, the governor from the US state of Delaware, will also be a guest at the event and companies from around the region can submit an application via the Internet at www.biobusinessasia.com.
Presentations at the event include how to develop business models and marketing plans, with an aim to help make Taiwan "a window, a marketplace, for new investment," Lee said.
If Biobusiness Asia works out well, "we will do it again next year," he added.
EUROPEAN TARGETS: The planned Munich center would support TSMC’s European customers to design high-performance, energy-efficient chips, an executive said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday said that it plans to launch a new research-and-development (R&D) center in Munich, Germany, next quarter to assist customers with chip design. TSMC Europe president Paul de Bot made the announcement during a technology symposium in Amsterdam on Tuesday, the chipmaker said. The new Munich center would be the firm’s first chip designing center in Europe, it said. The chipmaker has set up a major R&D center at its base of operations in Hsinchu and plans to create a new one in the US to provide services for major US customers,
BEIJING’S ‘PAWN’: ‘We, as Chinese, should never forget our roots, history, culture,’ Want Want Holdings general manager Tsai Wang-ting said at a summit in China The Mainland Affairs Council (MAC) yesterday condemned Want Want China Times Media Group (旺旺中時媒體集團) for making comments at the Cross-Strait Chinese Culture Summit that it said have damaged Taiwan’s sovereignty, adding that it would investigate if the group had colluded with China in the matter and contravened cross-strait regulations. The council issued a statement after Want Want Holdings (旺旺集團有限公司) general manager Tsai Wang-ting (蔡旺庭), the third son of the group’s founder, Tsai Eng-meng (蔡衍明), said at the summit last week that the group originated in “Chinese Taiwan,” and has developed and prospered in “the motherland.” “We, as Chinese, should never
‘ABUSE OF POWER’: Lee Chun-yi allegedly used a Control Yuan vehicle to transport his dog to a pet grooming salon and take his wife to restaurants, media reports said Control Yuan Secretary-General Lee Chun-yi (李俊俋) resigned on Sunday night, admitting that he had misused a government vehicle, as reported by the media. Control Yuan Vice President Lee Hung-chun (李鴻鈞) yesterday apologized to the public over the issue. The watchdog body would follow up on similar accusations made by the Chinese Nationalist Party (KMT) and would investigate the alleged misuse of government vehicles by three other Control Yuan members: Su Li-chiung (蘇麗瓊), Lin Yu-jung (林郁容) and Wang Jung-chang (王榮璋), Lee Hung-chun said. Lee Chun-yi in a statement apologized for using a Control Yuan vehicle to transport his dog to a
‘A SURVIVAL QUESTION’: US officials have been urging the opposition KMT and TPP not to block defense spending, especially the special defense budget, an official said The US plans to ramp up weapons sales to Taiwan to a level exceeding US President Donald Trump’s first term as part of an effort to deter China as it intensifies military pressure on the nation, two US officials said on condition of anonymity. If US arms sales do accelerate, it could ease worries about the extent of Trump’s commitment to Taiwan. It would also add new friction to the tense US-China relationship. The officials said they expect US approvals for weapons sales to Taiwan over the next four years to surpass those in Trump’s first term, with one of them saying
RSS